{"id":55441,"date":"2023-04-03T11:05:56","date_gmt":"2023-04-03T09:05:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/"},"modified":"2023-04-03T11:05:56","modified_gmt":"2023-04-03T09:05:56","slug":"global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/","title":{"rendered":"Global Neurology Clinical Trials Market Report to 2030: Significant Number of CROs Providing Neurology Clinical Research Services Drives Growth &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5457652\/neurology-clinical-trials-market-size-share-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=kvvgj4&amp;utm_campaign=1835812+-+Global+Neurology+Clinical+Trials+Market+Report+to+2030%3A+Significant+Number+of+CROs+Providing+Neurology+Clinical+Research+Services+Drives+Growth&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Neurology Clinical Trials Market Size, Share &amp; Trends Analysis Report By Phase (Phase I, Phase II), By Study Design (Interventional), By Indication, By Region, And Segment Forecasts, 2022 &#8211; 2030&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230403005464\/en\/1754057\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230403005464\/en\/1754057\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global neurology clinical trials market size is expected to reach USD 8,052.9 million by 2030, registering a CAGR of 5.6% from 2023 to 2030.<\/p>\n<p>\n<strong>Companies Mentioned<\/strong><\/p>\n<ul>\n<li>\nNovartis<\/li>\n<li>\nCovance<\/li>\n<li>\nMed pace<\/li>\n<li>\nCharles River Laboratories<\/li>\n<li>\nSyneous Health<\/li>\n<li>\nIcon Plc<\/li>\n<li>\nGlaxoSmithKline<\/li>\n<li>\nAurora healthcare<\/li>\n<li>\nBiogen<\/li>\n<li>\nIQVIA<\/li>\n<\/ul>\n<p>\nThis is largely attributed to big pharma companies conducting innovative trials in neurology, increased government funding from the National Institute of Neurological Disorders and Stroke (NINDS), and the high prevalence of neurological disorders worldwide.<\/p>\n<p>\nNeuroscience continues to receive a healthy investment. For instance, in November 2022, NRG Therapeutics raised Series A funding of USD 18.3 million for the development of mitochondrial therapeutics to treat neurodegenerative ailments such as amyotrophic lateral sclerosis (ALS) and Parkinson&#8217;s disease. The adoption of similar initiatives in the future is expected to support market growth.<\/p>\n<p>\nA significant number of people worldwide suffer from neurological disorders. For instance, as per the statistics from Parkinson&#8217;s Foundation, every year 60,000 Americans are diagnosed with PD and more than 10 million people are living with the disease around the world.<\/p>\n<p>\nIn terms of Epilepsy, the WHO states that more than 65 million people worldwide are affected by it. The disease is most prevalent in low- and middle-income countries, which account for 80.0% of epilepsy cases. A high prevalence of neurological disorders is expected to boost demand for clinical trials and thus support the market.<\/p>\n<p>\nNeurology is considered as one of the major areas where clinical trials are conducted. As per the Pharma R&amp;D Annual Review, in 2021, Neurology trials were the third area where clinical trials were majorly focused.<\/p>\n<p>\nThe Pharma R&amp;D Annual Review stated that for neurology above 2,900 drugs were under trial and in the year 2022 the number of drugs for clinical studies in the area of neurology accounted for more than 3,200 active drugs. An increasing number of drugs entering clinical trials in the area of neurology are expected to support the market in the post-pandemic period.<\/p>\n<p>\n<strong>Neurology Clinical Trials Market Report Highlights<\/strong><\/p>\n<ul>\n<li>\nThe phase II segment dominated the market and accounted for a maximum revenue share of 46.3% in 2022. A majority number of neurology clinical trials are currently in Phase 2, this is supporting the segment market<\/li>\n<li>\nThe interventional segment held the largest market revenue share of 96.1% in 2022. A high number of neurology clinical trials conducted through this study design type is promoting the growth of the segment market<\/li>\n<li>\nThe Huntington&#8217;s disease segment is anticipated to register the fastest CAGR of 6.0% during the forecast period. This is largely due to the fact that there is a high demand for the medicines used for Huntington&#8217;s disease worldwide as there are no medications available for treating this disease<\/li>\n<li>\nNorth America dominated the market and accounted for a revenue share of 47.0% in 2022. The rising prevalence of neurological disorders and the presence of a large number of players in clinical trials drive the market in the region. These are some of the key reasons for the high market share<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong><\/p>\n<p>\n<strong>Chapter 1. Methodology and Scope<\/strong><\/p>\n<p>\n<strong>Chapter 2. Executive Summary<\/strong><\/p>\n<p>\n<strong>Chapter 3. Neurology Clinical Trials Market Variables, Trends &amp; Scope<\/strong><\/p>\n<p>\n3.1. Market Lineage Outlook<\/p>\n<p>\n3.1.1. Parent market outlook<\/p>\n<p>\n3.1.2. Related\/ancillary market outlook<\/p>\n<p>\n3.2. Penetration &amp; growth prospect mapping<\/p>\n<p>\n3.3. Market Dynamics<\/p>\n<p>\n3.3.1. Market driver analysis<\/p>\n<p>\n3.3.1.1. Increasing prevalence of neurological diseases such as Alzheimer disease, epilepsy, and stroke<\/p>\n<p>\n3.3.1.2. Growing adoption of novel technologies in clinical research<\/p>\n<p>\n3.3.1.3. Significant number of CROs providing neurology clinical research services<\/p>\n<p>\n3.3.1.4. Increasing funding for neurological studies by public organizations<\/p>\n<p>\n3.3.2. Market restraint analysis<\/p>\n<p>\n3.3.2.1. High cost associated with neurology clinical studies.<\/p>\n<p>\n3.3.2.2. High failure rate coupled with patient dropout issues associated with neurological clinical trials.<\/p>\n<p>\n3.4. Neurology Clinical Trials Market Analysis Tools<\/p>\n<p>\n3.4.1. Porter&#8217;s Five Forces Analysis<\/p>\n<p>\n3.4.2. PEST Analysis<\/p>\n<p>\n3.5. COVID-19 Impact and Reformation Strategy<\/p>\n<p>\n<strong>Chapter 4. Neurology Clinical Trials Market: Phase Estimates &amp; Trend Analysis<\/strong><\/p>\n<p>\n<strong>Chapter 5. Neurology Clinical Trials Market: Study Design Estimates &amp; Trend Analysis<\/strong><\/p>\n<p>\n<strong>Chapter 6. Neurology Clinical Trials Market: Indication Estimates &amp; Trend Analysis<\/strong><\/p>\n<p>\n<strong>Chapter 7. Neurology Clinical Trials Market: Indication By Study Design Estimates &amp; Trend Analysis<\/strong><\/p>\n<p>\n<strong>Chapter 8. Neurology Clinical Trials Market: Indication By Phase Estimates &amp; Trend Analysis<\/strong><\/p>\n<p>\n<strong>Chapter 9. Neurology Clinical Trials Market: Regional Estimates &amp; Trend Analysis<\/strong><\/p>\n<p>\n<strong>Chapter 10. Competitive Landscape<\/strong><\/p>\n<p>\n<strong>Chapter 11. Company Profiles<\/strong><\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5457652\/neurology-clinical-trials-market-size-share-and?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=kvvgj4&amp;utm_campaign=1835812+-+Global+Neurology+Clinical+Trials+Market+Report+to+2030%3A+Significant+Number+of+CROs+Providing+Neurology+Clinical+Research+Services+Drives+Growth&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/qlda2i<\/a><\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong><\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;&#111;&#x3a;p&#114;&#x65;s&#x73;&#x40;&#114;&#x65;s&#101;&#x61;r&#x63;&#x68;&#97;&#x6e;d&#109;&#x61;&#114;&#x6b;e&#116;&#x73;&#46;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;e&#x73;&#x73;&#64;r&#x65;&#115;e&#x61;&#x72;&#99;h&#x61;&#110;d&#x6d;&#x61;&#114;k&#x65;&#x74;&#115;&#x2e;&#x63;&#111;m<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Neurology Clinical Trials Market Size, Share &amp; Trends Analysis Report By Phase (Phase I, Phase II), By Study Design (Interventional), By Indication, By Region, And Segment Forecasts, 2022 &#8211; 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global neurology clinical trials market size is expected to reach USD 8,052.9 million by 2030, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55441","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Neurology Clinical Trials Market Report to 2030: Significant Number of CROs Providing Neurology Clinical Research Services Drives Growth - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Neurology Clinical Trials Market Report to 2030: Significant Number of CROs Providing Neurology Clinical Research Services Drives Growth - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Neurology Clinical Trials Market Size, Share &amp; Trends Analysis Report By Phase (Phase I, Phase II), By Study Design (Interventional), By Indication, By Region, And Segment Forecasts, 2022 &#8211; 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global neurology clinical trials market size is expected to reach USD 8,052.9 million by 2030, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-03T09:05:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230403005464\/en\/1754057\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Neurology Clinical Trials Market Report to 2030: Significant Number of CROs Providing Neurology Clinical Research Services Drives Growth &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-04-03T09:05:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\\\/\"},\"wordCount\":830,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230403005464\\\/en\\\/1754057\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\\\/\",\"name\":\"Global Neurology Clinical Trials Market Report to 2030: Significant Number of CROs Providing Neurology Clinical Research Services Drives Growth - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230403005464\\\/en\\\/1754057\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-04-03T09:05:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230403005464\\\/en\\\/1754057\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230403005464\\\/en\\\/1754057\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Neurology Clinical Trials Market Report to 2030: Significant Number of CROs Providing Neurology Clinical Research Services Drives Growth &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Neurology Clinical Trials Market Report to 2030: Significant Number of CROs Providing Neurology Clinical Research Services Drives Growth - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Neurology Clinical Trials Market Report to 2030: Significant Number of CROs Providing Neurology Clinical Research Services Drives Growth - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Neurology Clinical Trials Market Size, Share &amp; Trends Analysis Report By Phase (Phase I, Phase II), By Study Design (Interventional), By Indication, By Region, And Segment Forecasts, 2022 &#8211; 2030&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global neurology clinical trials market size is expected to reach USD 8,052.9 million by 2030, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-03T09:05:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230403005464\/en\/1754057\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Neurology Clinical Trials Market Report to 2030: Significant Number of CROs Providing Neurology Clinical Research Services Drives Growth &#8211; ResearchAndMarkets.com","datePublished":"2023-04-03T09:05:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/"},"wordCount":830,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230403005464\/en\/1754057\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/","name":"Global Neurology Clinical Trials Market Report to 2030: Significant Number of CROs Providing Neurology Clinical Research Services Drives Growth - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230403005464\/en\/1754057\/21\/logo.jpg","datePublished":"2023-04-03T09:05:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230403005464\/en\/1754057\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230403005464\/en\/1754057\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-neurology-clinical-trials-market-report-to-2030-significant-number-of-cros-providing-neurology-clinical-research-services-drives-growth-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Neurology Clinical Trials Market Report to 2030: Significant Number of CROs Providing Neurology Clinical Research Services Drives Growth &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55441"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55441\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}